Work

Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma

Year: 2023

Type: article

Source: Targeted Oncology

DOI: 10.1007/s11523-023-01006-z

Authors: Ning Wang, Zhenxian Mo, Lu Pan, Minhua Zhou, Xiaolan Ye, Xinjian Liu, Xiong Cai, Changgeng Qian, Feili Chen, Yan Xiong, Fushun Fan, Wenyu Li

Institutions: Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University, South China University of Technology, Jinan University, Curis (United States)

Language: English

Topic: CNS Lymphoma Diagnosis and Treatment

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Science and Technology Major Project, Guangdong Provincial Pearl River Talents Program, Guangzhou Municipal Science and Technology Project

Awards: G1775552615, G2497063385, G5852901622

OpenAlex ID: W4387765614

FWCI: 2.586

Cites: 34

Cited by: 16

Related to: 10